Skip to main content
. 2019 Jul 17;9:10326. doi: 10.1038/s41598-019-46876-4

Figure 3.

Figure 3

Relative methylation levels of mSEPT9 in colorectal cancer at different time points. Relative methylation of mSEPT9 (line = median) in colorectal cancer (CRC) patients (a) with or without recurrence; (b) with or without new metastases; (c) with or without death; (d) with poor or better prognosis during follow-up after operation. Poor prognosis refers to the presence of any of the three mentioned prognostic factors, while better prognosis refers to none of them. The P value was calculated by paired t test through GraphPad Prism (version 7; GraphPad Software, San Diego, CA) and represented the significance level of the difference in each group as aforesaid. The dots represent the mean value of SEPT9 methylation level in three PCR reactions for each individual patient, while the dotted lines show the trend of the median methylation levels with time. Pre = pre-operation, M = months.